Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
LSE:AZN
AstraZeneca PLC
|
123.70 | 16,41% | 38,64% | 191.764,07 | 2,01% | 15,98% |
|
NYSE:ABT
Abbott Laboratories
|
104.74 | 1,79% | 14,45% | 182.209,24 | 2,1% | 9,04% |
|
NasdaqGS:AMGN
Amgen
|
310.15 | -11,6% | -2,74% | 166.375,22 | 2,88% | 5,31% |
|
ENXTBR:ABI
Anheuser-Busch InBev SA/NV
|
59.48 | 10,92% | 29,33% | 117.936,56 | 1,39% | -2,38% |
|
LSE:GSK
GSK
|
18.00 | 5,94% | 21,55% | 73.384,28 | 3,26% | 0,79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.94 | 58,46% | 68,59% | 91.097,88 | 5,36% | 13,54% |
|
NYSE:BDX
Becton Dickinson and Co
|
235.67 | 15,76% | 29,91% | 68.110,15 | 1,62% | 2,09% |
|
TSE:4568
Daiichi Sankyo Company
|
5385.00 | 0% | 0% | 10.322.749,31 | 1,15% | 0% |
|
NYSE:MMM
3M
|
98.93 | 67,8% | 83,94% | 54.744,03 | 6,21% | -2,45% |
|
TSE:4519
Chugai Pharmaceutical
|
4946.00 | 0% | 0% | 8.137.722,82 | 1,67% | 0% |
|
SWX:ALC
Alcon
|
73.60 | 19,64% | 36,44% | 36.302,79 | 0,33% | 5,47% |
|
XTRA:BEI
Beiersdorf
|
147.25 | -3,19% | 7,7% | 32.957,35 | 0,69% | 3,11% |
|
NasdaqGS:BIIB
Biogen
|
221.50 | -11,75% | 3,9% | 32.249,71 | 0% | -10,89% |
|
XTRA:BAYN
Bayer
|
28.96 | 65,34% | 81,47% | 28.446,09 | 0,38% | 1,47% |
|
TSE:4452
Kao
|
6939.00 | 0% | 0% | 3.225.695,9 | 2,19% | 0% |
|
CPSE:GMAB
Genmab A/S
|
2003.00 | 67,93% | 128,66% | 129.376,32 | 0% | 22,71% |
|
NasdaqGS:BGNE
BeiGene
|
161.13 | 0% | 0% | 16.850,78 | 0% | 0% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
81.03 | 142,2% | 221,62% | 15.385,96 | 0% | 32,46% |
|
TSE:4523
Eisai
|
6793.00 | 0% | 0% | 1.918.445,23 | 2,39% | 0% |
|
NasdaqGS:INCY
Incyte
|
53.06 | 104,81% | 153,29% | 12.012,93 | 0% | 27,62% |
